Tula, Tula, Russian Federation
UDK 61 Медицина. Охрана здоровья
Chronic lymphocytic leukemia is one of the most common types of leukemia. Chronic lymphocytic leukemia is more common in men, the ratio of men and women who become ill is 2:1. Infectious complications are the main cause of death in patients with CLL. Mortality from infections is 30-50% of all fatal cases. Despite significant progress in therapy, CLL remains an incurable disease. The current goal of treatment is to increase the proportion of overall survival and progression-free survival with minimal toxicity. A clinical observation of a patient with chronic lymphocytic leukemia and a good response to therapy according to the RFC scheme is presented.
chronic lymphocytic leukemia, diagnosis, protocols of polychemotherapy
1. Volkova, M. A. Hronicheskiy limfoleykoz // Klinicheskaya onkogematologiya. Izdanie vtoroe pererabotannoe i dopolnennoe / M. A. Volkova. – M., 2007. – S. 771 – 807.
2. Vorob'ev, A. I. Rukovodstvo po gematologii v 2 tomah. – M.: N'yudiamed, 2005. – 2t.
3. Dvoreckiy, L. I. Differencial'nyy diagnoz pri limfadenopatiyah. Spravochnik poliklinicheskogo vracha v 3 tomah. – M.: Media Medika, 2005. – 3t.
4. Klyasova, G. A. Profilaktika i lechenie infekcionnyh oslozhneniy // Rukovodstvo po gematologii / pod red. A. I. Vorob'eva. – 3-e izd., pererab. i dop. – M., 2003. – T. 2. – S. 210–230.
5. Kovrigin, A. M. Morfologicheskaya harakteristika reaktivnyh izmeneniy limfouzlov // A.M Kovrigin / Klinicheskaya onkogematologiya. – 2009. – № 4. – S. 297–306.
6. Nekotorye aspekty diagnostiki i lecheniya V-kletochnogo hronicheskogo limfoleykoza / Voycehovskiy V.V. [i dr.] // Sibirskiy medicinskiy zhurnal. – 2007. – № 1. – S. 72 – 75.
7. Nikitin, E. A Faktory neblagopriyatnogo prognoza u bol'nyh V – kletochnym hronicheskim limfoleykozom: retrosp. analiz 206 sluchaev / E. A. Nikitin, Yu. Yu. Lorie, A. L. Melikyan // Ter. arhiv. – 2003. – № 7. – S. 38–47.
8. Nikitin E.A. Protokol lecheniya hronicheskogo limfoleykoza: differencirovannaya terapiya v zavisimosti ot vozrasta i komorbidnosti bol'nyh // Programmnoe lechenie zabolevaniy sistemy krovi / pod red. V.G. Savchenko. – M., 2012. – S. 469 – 496.
9. Cvirnovskiy, A. I. Prognozirovanie pri hronicheskom limfocitarnom leykoze na etape razrabotki novyh metodov terapii i intensivnogo razvitiya predstavleniy o biologii zabolevaniya / A. I. Svirnovskiy // Medicinskie novosti. – 2012. – № 11 (218). – S. 6–12.
10. Sovremennaya lekarstvennaya terapiya i prognosticheskie faktory pri hronicheskom limfoleykoze. Obzor literatury i sobstvennye dannye / E. A. Stadnik [i dr.] // Byulleten' sibirskoy mediciny. – 2008 – № 3. – S. 42-52.
11. Stadnik, E.A. Hronicheskiy limfoleykoz. Rekomendacii po diagnostike i lecheniyu / E.A. Stadnik [i dr.] // Byullleten' Federal'nogo Centra serdca, krovi i endokrinologii im. V.A. Almazova. – 2012 – №4. – S. 5–15.
12. Hronicheskiy limfoleykoz / V. V. Voycehovskiy [i dr.]. – Blagoveschensk, GBO UVPO AGMA, 2015. – 192s.
13. Zagoskina, T.P. Effektivnost' kombinacii rituksimaba, fludarabina i ciklofosfana pri lechenii hronicheskogo limfoleykoza / T.P. Zagoskina // Gematol. i transfuziol. – 2006 – t. 51. – № 6. – S. 12-16.
14. Mehanizmy zaprogrammirovannoy kletochnoy gibeli. Apoptoz. http://toxicology.narod.ru/book30 .html
15. Osmanov, D.Sh. Sindrom Rihtera / D.Sh.Osmanov // Klinicheskaya onkogematologiya. – M., Medicina. – 2001. – S. 393-395
16. Bazemore, A., Smucker D. Lymphadenopathy and malignancy / A. Bazemore, D. Smucker // Am Fam Physician, 2002. - №66. – R. 2103–2110.
17. Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia / L. Z. Rassenti [et al.] // Blood. – 2008. – Vol. 112, № 5. – P. 1923–1930. 116
18. Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia / R. Claus [et al.] // Blood, 2014. – Vol. 124, iss. 1. – P. 42–48
